Pancreatic Cancer Research

ResearcherUniversity of WashingtonNo recent work listed

Feng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5629-5571; OpenAlex author ID A5100401193. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Radiofrequency Hyperthermia Enhances Locally Delivered Oncolytic Immuno-Virotherapy for Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s00270-022-03210-2↗
  2. TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.665265↗
  3. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer. Co-author DOI 10.18632/oncotarget.12295↗
  4. Diffusion-weighted MRI monitoring of pancreatic cancer response to radiofrequency heat-enhanced intratumor chemotherapy. First author DOI 10.1002/nbm.3014↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoming Yang · 3 shared papers, 2013–2022 · strength 0.31
  2. Qiang Li · 1 shared paper, 2022 · strength 0.20
  3. Yu-bin Liu · 1 shared paper, 2021 · strength 0.16
  4. Min Yu · 1 shared paper, 2021 · strength 0.16
  5. Zhibin Bai · 1 shared paper, 2017 · strength 0.07
  6. Donghoon Lee · 1 shared paper, 2013 · strength 0.03
  7. Han Wang · 1 shared paper, 2013 · strength 0.03
  8. Tong Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.